This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2014 Nov;40(10):1243.

doi: 10.1111/apt.12958.

Editorial: long-term safety and efficacy of certolizumab pegol for Crohn's disease

M Cesarini¹, S Danese

Affiliations

PMID: 25303376
DOI: 10.1111/apt.12958

Editorial

Editorial: long-term safety and efficacy of certolizumab pegol for Crohn's disease

M Cesarini et al. Aliment Pharmacol Ther. 2014 Nov.

. 2014 Nov;40(10):1243.

doi: 10.1111/apt.12958.

Authors

M Cesarini¹, S Danese

Affiliation

¹ Dipartimento di Medicina Interna e Specialità Mediche, Sapienza University of Rome, Rome, Italy. cesarini.monica@yahoo.it.

PMID: 25303376
DOI: 10.1111/apt.12958

No abstract available

PubMed Disclaimer

Comment on

Long-term safety and efficacy of certolizumab pegol in the treatment of Crohn's disease: 7-year results from the PRECiSE 3 study.
Sandborn WJ, Lee SD, Randall C, Gutierrez A, Schwartz DA, Ambarkhane S, Kayhan C, Pierre-Louis B, Schreiber S, Lichtenstein GR. Sandborn WJ, et al. Aliment Pharmacol Ther. 2014 Oct;40(8):903-16. doi: 10.1111/apt.12930. Epub 2014 Aug 22. Aliment Pharmacol Ther. 2014. PMID: 25146586 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information